Prof Jeroen Dekervel, a GI oncologist from Leuven, Belgium, and Prof Julien...
The KEYNOTE-859 study investigated the efficacy of pembrolizumab combined with...
Mitazalimab, a human CD40 agonistic IgG1 antibody, shows promise by reducing...
Prof Prenen highlights one significant trial, the Ragnar trial, which resulted...
In this interview, Prof Arndt Vogel, a GI oncologist from Toronto, discusses...
Study 22 was a phase I/II trial evaluating different immune checkpoint...
During the 2024 ASCO GU meeting earlier this year, the CheckMate 8HW study...
Previously, the phase III EMERALD-1 trial showed that a regimen combining...
Prof Dr Jeroen Dekervel from UZ Leuven (Belgium) and Prof Dr Florian Lordick...
Dr Willem Lybaert, a medical oncologist at the VITAZ Sint-Niklaas & University...